Romania's nuclear power plant operator Nuclearelectrica and France's Framatome are aiming to launch a full-scale commercial irradiation service for medical isotopes in 2028.
TerraPower Isotopes announced it is producing actinium-225 at commercial scale. The medical radioisotope is being produced from material recovered from a legacy uranium-233 inventory at a US national laboratory.